NCT07287163Enrolling by invitationPhase 3
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- First submitted
- 11 Dec 2025
- Start date
- 27 Oct 2025
- Primary completion date
- 31 May 2028
- Lead sponsor
- Praxis Precision Medicines
- Diseases
- Epilepsy
- NCT number
- NCT07287163
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 700
- From 27 Oct 2025 to the primary completion date, 31 May 2028
- 36 sites in 6 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participant who plans to enter another interventional investigational study or is on any prohibited medication
Other
- Participant who withdrew or discontinued treatment from the treatment period of an eligible clinical trial unless deemed acceptable by the sponsor
- Participant who is pregnant, lactating or planning to become pregnant
- Participant who is ineligible for the extension clinical trial in the view of the investigator
Who the study is looking for
- Participant who completed an eligible clinical trial (unless agreed by the sponsor medical monitor), including PRAX-628-212, PRAX-628-321 or other vormatrigine trials, or participant who has received vormatrigine outside of an eligible clinical trial (such as an expanded access program)
- Participant who had adequate seizure diary and vormatrigine adherence and had been otherwise adherent to the study procedures in the opinion of the investigator unless deemed unacceptable by sponsor
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (36)
Sites in registry order. Pick your city on the disease page to sort them by distance.
This page is information, not medical advice. Discuss any trial with your doctor.